Astera Labs (NASDAQ:ALAB) Raised to “Outperform” at Northland Securities

Astera Labs (NASDAQ:ALAB) was upgraded by equities researchers at Northland Securities from a “market perform” rating to an “outperform” rating in a research note issued on Monday,Benzinga reports. The brokerage presently has a $350.00 target price on the stock. Northland Securities’ price target would indicate a potential upside of 8.83% from the stock’s previous close.

A number of other research analysts have also recently weighed in on the stock. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Bank of America raised their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Needham & Company LLC boosted their price objective on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Morgan Stanley increased their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Stock Performance

Astera Labs stock opened at $321.61 on Monday. Astera Labs has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market capitalization of $55.80 billion, a price-to-earnings ratio of 159.21 and a beta of 3.84. The firm has a 50 day moving average of $358.00 and a 200 day moving average of $240.74.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs will post 2.7 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $3,276,963.90. Following the sale, the director directly owned 5,292 shares in the company, valued at approximately $1,928,140.20. The trade was a 62.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 28,737 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the completion of the sale, the chief executive officer owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. The trade was a 0.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 940,716 shares of company stock valued at $292,425,777 in the last ninety days. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently made changes to their positions in ALAB. Reflection Asset Management purchased a new position in Astera Labs during the 4th quarter valued at approximately $25,000. Keating Financial Advisory Services Inc. purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC boosted its position in shares of Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.